Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Gamma Pharmaceuticals Inc. (the "Company") (PINKSHEETS: GMPM) announced it has successfully completed the registration of six of the Company's Brand Trademarks with The State Trademark Bureau of China. This important milestone is the conclusion of a two-year registration process and will provide Gamma with exclusivity of use and trademark protection on its commercial products in China.

Mr. Hao Zhang, Gamma's Chief Marketing Officer and China Representative, stated, "We are pleased to have the proper protection for our brands and recourse should there be any infringement. The Chinese nutritional supplement market is growing rapidly and we need to have the correct legal protections as we push our brand identity."

Gamma has a wholly owned subsidiary in Hong Kong and a Representative office in Beijing to facilitate its Asian business. Gamma's three founders have substantial business experience in Asia, having lived and worked there for nearly two decades. Gamma's management views the rapidly growing Chinese market as a key growth driver for the Company and have budgeted approximately $13 million in revenues for 2010 from the region. Gamma's intellectual property assets total nearly $6 million on the Company's balance sheet. Management's extensive Intellectual Property Management Program is designed to both protect these important assets and to grow their value.